![](/img/cover-not-exists.png)
Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer
Professor Christoph Rochlitz, Robert Figlin, Patrick Squiban, Marc Salzberg, Miklos Pless, Richard Herrmann, Eric Tartour, Yongxiang Zhao, Nadine Bizouarne, Martine Baudin, Bruce AcresVolume:
5
Year:
2003
Language:
english
Pages:
10
DOI:
10.1002/jgm.397
File:
PDF, 145 KB
english, 2003